Disabling Hip Osteoarthritis and Cardiovascular Pathology: Presence and Impact
Abstract
Objective: This study examined: 1) the extent to which cases with disabling end-stage hip osteoarthritis would exhibit co-occurring cardiovascular health conditions; 2) the pre and post-surgical impact of the presence of one or more of these health conditions on walking ability. Methods: First, a frequency analysis of the various cardiovascular health conditions listed among 1000 end-stage hip osteoarthritis cases was conducted. Second, a sub-sample of 823 uncomplicated surgical cases was specifically examined. Third, a matched sub-sample of 60 cases with and without co-occurring cardiovascular conditions were compared as regards pain, and their ability to functional physically before and after surgery. Results: Almost 50% of cases initially examined had one or more cardiovascular conditions. Among the 10 categories listed, the most common was high blood pressure, found in 28% cases. Significant (p < .05) associations between having one or more cardiovascular comorbidities and high body mass indices were observed, and co-occurring cardiovascular disease independently predicted walking capacity before and after surgery. Key conclusions: Patients with disabling hip osteoarthritis may exhibit high rates of comorbid cardiovascular health conditions. Those presenting with one or more of cardiovascular condition, may have poorer mobility, both before and after surgery than those with no cardiovascular conditions.
About this article
References
G.M. Van Dijk C. Veenhof, G.J. Lankhorst, et al., “Limitations in patients with osteoarthritis of the hip and knee: The relationship with body functions, comorbidity and cognitive function”, Disabilityand Rehabilitation, 3, 20, (2009), 1685-1691.
G. M. Van Dijk, C. Veenhof, F. Schellevis, et al., “Comorbidity, limitations in activities and pain in patients with osteoarthritis”, BioMedCentral Musculoskeletal Diseases, 9, (2008), 95. doi:10.1186/1471-2474-9-95.
J. Dekker, G.M. Van Dijk, C. Veenhof, “Risk factors for functional decline in osteoarthritis of the hip or knee”, Current Opinion in Rheumatology, 21, 5, (2009), 520-524.
M. I. O’Connor, “Osteoarthritis of the hip and knee: sex and gender differences”, Orthopedic Clinics of North America, 37, 4, (2006), 559-568.
D.T. Felson, “An update on the pathogenesis and epidemiology of osteoarthritis”, Radiological Clinics of North America, 42, 1, (2004), 1-9.
View more references (31)
F. Cecchi, A. Mannoni, R. S. Molino-Lova et al., “Epidemiology of hip and knee pain in a community based sample of Italian persons aged 65 and older”, Osteoarthritis and Cartilage, 16, 9, (2008), 1039-1046.
S. M. A. Bierma-Zeinstra, A. P. Verhagen, “Osteoarthritis subpopulations and implications for clinical trial design”, Arthritis Research and Therapy, 13, 2, (2011), 213.
P. Dieppe, A. Judge, S. Williams, et al., “Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres”, BioMedCentral Musculoskeletal Disorders, 19, (2009), 19.
C.P. Diederichs, J. Wellmann, D.B. Bartels, et al., “How to weight chronic diseases in multimorbidity indices? Development of a new method on the basis of individual data from five population-based studies”, Journal of Clinical Epidemiology, 65, 6, (2012), 679-685.
D. van der Linde D, I.M. van de Laar, A.M. Bertoli-Avella, et al., “Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants”, Journal of the American College of Cardiology, 60, 5, (2012), 397-403.
D. J. Margolis, J. Knauss, W. Bilker, “Medical conditions associated with venous leg ulcers”, British Journal of Dermatology, 150, 2, (2004), 267-273.
P.R. Kornaat, R. Sharma, R.J. Van Der Geest, et al., “Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?”, Skeletal Radiology, 38, 12, (2009), 1147-1151.
A. Tukker, T.L. Visscher, H.S. Picavet, “Overweight and health problems of the lower extremities: osteoarthritis, pain and disability”, Public Health Nutrition, 12, 3, (2009), 359-368.
C.C. Arnoldi, H. Linderholm, H. Mussbichler, “Venous engorgement and intraosseus hypertension in osteoarthritis of the hip”, Journal of Bone and Joint Surgery, 54B, 3, (1972), 409-421.
L. Markovic-Denic, K. Zivkovic, A. Lesic, et al., “Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study”, International Orthopedics, 36, 6, (2012), 1299-1305.
E. Odding, H.A.Valkenberg, H.J. Stam, et al., “Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study”, European Journal of Epidemiology, 17, 11, (2001), 1033-1041.
M. Gore, K.S. Tai, A. Sadosky, et al., “Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis”, Journal of MedicalEconomics,14,4, (2011), 497-507.
M. Dougados, A. Guegen, M. Mguyen, et al., “Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status”, Annals of the Rheumatic Diseases, 55, 6, (1996), 356-362.
J.F. Maillefert, A. Guegen, M. Monreal, et al., “Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients”, Annals of the Rheumatic Diseases, 62, 10, (2003), 931-934.
G. Singh, J.D. Miller, F.H. Lee, et al., “Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the third national Health and Nutrition Survey”, American Journal of Managed Care, 15, Suppl, (2002), S383-391.
M.M. J. Nielen, A. M. van Sijl M.J.L. Peters, et al., “Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care”, BioMedCentral Musculoskeletal Disorders, 13, (2012), 150.
R. Juhakoski, S. Tenhonen, T. Anttonen, et al., “Factors affecting self-reported pain and physical function in patients with hip osteoarthritis”, Archives of Physical Medicine and Rehabilitation, 89, 6, (2008), 1066-1073.
M. Brandes, M. Ringling, C. Winter, et al., “Changes in physical activity and health-related quality of life during the first year after total knee arthroplasty”, Arthritis Care Research, 63, 3, (2011), 328-334.
H. St. C.C.Addis, R.P. Jepson, J.H. Kellgren, “On the effect of arteriol occlusion and venous congestion upon limb pain”, Clinical Science, 9, (1950), 271-280.
A. Martocchia, L. Toussan, M. Stefanelli, et al., “Association of severity of osteoarthritis and carotid atherosclerosis in patients with metabolic syndrome”, Rheumatology, 1 (2011), 1.
G. Schett, S. Kiechi, E. Bonara, et al., “Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints”, Arthritis and Rheumatism, 60, 8, (2009), 2381-2389.
D. M. Findlay, “Vascular pathology and osteoarthritis”, Rheumatology, 46, 12, (2007), 1763-1768.
L. Haywood, D. F. McWilliams, C.I. Pearson, et al., “Inflammation and angiogenesis in osteoarthritis”, Arthritis and Rheumatism, 48, 8, (2003), 2173-2177.
N. Neusch, P. Dieppe, S. Reichenbach, et al., “All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study”, British Medical Journal, 342, (2011), March 8.
M.M. Rahman, J.A. Kopec, J. Cibere, et al., “The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study”, British Medical Journal Open, 3, (2013), 5.
F. C. Breedveld, “Osteoarthritis--the impact of a serious disease”, Rheumatology (Oxford), 43, Suppl 1, (2004), S4-8.
T.J. Peters, C. Sanders, P. Dieppe, et al., “Factors associated with change in pain and disability over time: a community-based prospective observational study of hip and knee osteoarthritis”, British Journal of General Practice, 55, 512, (2005), 205-211.
E. Yusuf, “Metabolic factors in osteoarthritis: obese people do not walk on their hands”, Arthritis Research and Therapy, 14, 4, (2012), 123.
R.A. Puenpatom, T.W. Victor, “Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data”, Postgraduate Medicine, 121, 6, (2009), 9-20.
K. L. Ong, B. J. Wu, B.M. Cheung, et al., “Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008”, Annals of Epidemiology, 23, 2, (2013), 80-86.
U. T. Kadam, A. Holmberg, M. Blagojevic, et al., “Risk factors for cardiovascular disease and future osteoarthritis-related arthroplasty: a population-based cohort study in men and women from Malmö, Sweden”, Scandinavian Journal of Rheumatology, 40, 6, (2011), 478-485.